ILLUMINA INC (ILU.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:ILU - US4523271090 - Common Stock
110.34 EUR
-0.26 (-0.24%)
We assign a fundamental rating of 6 out of 10 to ILU. ILU was compared to 20 industry peers in the Life Sciences Tools & Services industry. ILU scores excellent points on both the profitability and health parts. This is a solid base for a good stock. ILU has a correct valuation and a medium growth rate. These ratings could make ILU a good candidate for quality investing.
1. Profitability
1.1 Basic Checks
ILU had positive earnings in the past year.
In the past year ILU had a positive cash flow from operations.
In multiple years ILU reported negative net income over the last 5 years.
ILU had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
ILU's Return On Assets of 11.38% is amongst the best of the industry. ILU outperforms 95.00% of its industry peers.
Looking at the Return On Equity, with a value of 29.53%, ILU belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
ILU has a better Return On Invested Capital (14.61%) than 95.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.38% | ||
| ROE | 29.53% | ||
| ROIC | 14.61% |
ROA(3y)-22.28%
ROA(5y)-10.63%
ROE(3y)-46.16%
ROE(5y)-23.48%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
ILU has a better Profit Margin (16.39%) than 90.00% of its industry peers.
With an excellent Operating Margin value of 20.41%, ILU belongs to the best of the industry, outperforming 90.00% of the companies in the same industry.
In the last couple of years the Operating Margin of ILU has declined.
ILU has a Gross Margin of 66.74%. This is amongst the best in the industry. ILU outperforms 100.00% of its industry peers.
In the last couple of years the Gross Margin of ILU has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 20.41% | ||
| PM (TTM) | 16.39% | ||
| GM | 66.74% |
OM growth 3YN/A
OM growth 5Y-11.47%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.07%
GM growth 5Y-1.23%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ILU is still creating some value.
The number of shares outstanding for ILU remains at a similar level compared to 1 year ago.
The number of shares outstanding for ILU has been increased compared to 5 years ago.
The debt/assets ratio for ILU is higher compared to a year ago.
2.2 Solvency
ILU has an Altman-Z score of 4.27. This indicates that ILU is financially healthy and has little risk of bankruptcy at the moment.
ILU's Altman-Z score of 4.27 is fine compared to the rest of the industry. ILU outperforms 80.00% of its industry peers.
ILU has a debt to FCF ratio of 1.99. This is a very positive value and a sign of high solvency as it would only need 1.99 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 1.99, ILU belongs to the best of the industry, outperforming 95.00% of the companies in the same industry.
A Debt/Equity ratio of 0.42 indicates that ILU is not too dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.42, ILU belongs to the best of the industry, outperforming 85.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.42 | ||
| Debt/FCF | 1.99 | ||
| Altman-Z | 4.27 |
ROIC/WACC1.44
WACC10.18%
2.3 Liquidity
ILU has a Current Ratio of 1.43. This is a normal value and indicates that ILU is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.43, ILU is in line with its industry, outperforming 55.00% of the companies in the same industry.
A Quick Ratio of 1.12 indicates that ILU should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.12, ILU is doing good in the industry, outperforming 70.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.43 | ||
| Quick Ratio | 1.12 |
3. Growth
3.1 Past
ILU shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 152.02%, which is quite impressive.
Measured over the past years, ILU shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -17.93% on average per year.
The Revenue has decreased by -2.32% in the past year.
ILU shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.29% yearly.
EPS 1Y (TTM)152.02%
EPS 3Y-25.65%
EPS 5Y-17.93%
EPS Q2Q%17.54%
Revenue 1Y (TTM)-2.32%
Revenue growth 3Y-1.15%
Revenue growth 5Y4.29%
Sales Q2Q%0.37%
3.2 Future
ILU is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 24.49% yearly.
The Revenue is expected to grow by 3.93% on average over the next years.
EPS Next Y96.04%
EPS Next 2Y44.34%
EPS Next 3Y33.86%
EPS Next 5Y24.49%
Revenue Next Year-0.86%
Revenue Next 2Y0.6%
Revenue Next 3Y2.25%
Revenue Next 5Y3.93%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 29.50, the valuation of ILU can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of ILU is on the same level as its industry peers.
Compared to an average S&P500 Price/Earnings ratio of 26.34, ILU is valued at the same level.
Based on the Price/Forward Earnings ratio of 25.20, the valuation of ILU can be described as expensive.
ILU's Price/Forward Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.56, ILU is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29.5 | ||
| Fwd PE | 25.2 |
4.2 Price Multiples
ILU's Enterprise Value to EBITDA ratio is in line with the industry average.
ILU's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. ILU is cheaper than 80.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 19.65 | ||
| EV/EBITDA | 17.51 |
4.3 Compensation for Growth
ILU's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ILU has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as ILU's earnings are expected to grow with 33.86% in the coming years.
PEG (NY)0.31
PEG (5Y)N/A
EPS Next 2Y44.34%
EPS Next 3Y33.86%
5. Dividend
5.1 Amount
No dividends for ILU!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
FRA:ILU (12/8/2025, 7:00:00 PM)
110.34
-0.26 (-0.24%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners104.82%
Inst Owner ChangeN/A
Ins Owners0.18%
Ins Owner ChangeN/A
Market Cap16.86B
Revenue(TTM)4.29B
Net Income(TTM)703.00M
Analysts72.86
Price Target105.63 (-4.27%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.9%
Min EPS beat(2)12.52%
Max EPS beat(2)15.27%
EPS beat(4)3
Avg EPS beat(4)5.34%
Min EPS beat(4)-7.76%
Max EPS beat(4)15.27%
EPS beat(8)6
Avg EPS beat(8)97.15%
EPS beat(12)10
Avg EPS beat(12)231.96%
EPS beat(16)13
Avg EPS beat(16)178.01%
Revenue beat(2)0
Avg Revenue beat(2)-0.74%
Min Revenue beat(2)-1.21%
Max Revenue beat(2)-0.28%
Revenue beat(4)0
Avg Revenue beat(4)-0.66%
Min Revenue beat(4)-1.21%
Max Revenue beat(4)-0.18%
Revenue beat(8)3
Avg Revenue beat(8)-0.29%
Revenue beat(12)4
Avg Revenue beat(12)-0.57%
Revenue beat(16)5
Avg Revenue beat(16)-0.78%
PT rev (1m)6.5%
PT rev (3m)8.45%
EPS NQ rev (1m)-0.46%
EPS NQ rev (3m)2.73%
EPS NY rev (1m)1.32%
EPS NY rev (3m)4.19%
Revenue NQ rev (1m)-0.27%
Revenue NQ rev (3m)0.63%
Revenue NY rev (1m)0.21%
Revenue NY rev (3m)0.55%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29.5 | ||
| Fwd PE | 25.2 | ||
| P/S | 4.58 | ||
| P/FCF | 19.65 | ||
| P/OCF | 17.51 | ||
| P/B | 8.25 | ||
| P/tB | 18.84 | ||
| EV/EBITDA | 17.51 |
EPS(TTM)3.74
EY3.39%
EPS(NY)4.38
Fwd EY3.97%
FCF(TTM)5.62
FCFY5.09%
OCF(TTM)6.3
OCFY5.71%
SpS24.08
BVpS13.37
TBVpS5.86
PEG (NY)0.31
PEG (5Y)N/A
Graham Number33.54
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.38% | ||
| ROE | 29.53% | ||
| ROCE | 20.76% | ||
| ROIC | 14.61% | ||
| ROICexc | 20.97% | ||
| ROICexgc | 38.52% | ||
| OM | 20.41% | ||
| PM (TTM) | 16.39% | ||
| GM | 66.74% | ||
| FCFM | 23.32% |
ROA(3y)-22.28%
ROA(5y)-10.63%
ROE(3y)-46.16%
ROE(5y)-23.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-6.48%
ROICexc growth 3YN/A
ROICexc growth 5Y-9.28%
OM growth 3YN/A
OM growth 5Y-11.47%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.07%
GM growth 5Y-1.23%
F-Score7
Asset Turnover0.69
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.42 | ||
| Debt/FCF | 1.99 | ||
| Debt/EBITDA | 0.86 | ||
| Cap/Depr | 44.36% | ||
| Cap/Sales | 2.85% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 97.57% | ||
| Profit Quality | 142.25% | ||
| Current Ratio | 1.43 | ||
| Quick Ratio | 1.12 | ||
| Altman-Z | 4.27 |
F-Score7
WACC10.18%
ROIC/WACC1.44
Cap/Depr(3y)66.6%
Cap/Depr(5y)76.75%
Cap/Sales(3y)5.82%
Cap/Sales(5y)5.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)152.02%
EPS 3Y-25.65%
EPS 5Y-17.93%
EPS Q2Q%17.54%
EPS Next Y96.04%
EPS Next 2Y44.34%
EPS Next 3Y33.86%
EPS Next 5Y24.49%
Revenue 1Y (TTM)-2.32%
Revenue growth 3Y-1.15%
Revenue growth 5Y4.29%
Sales Q2Q%0.37%
Revenue Next Year-0.86%
Revenue Next 2Y0.6%
Revenue Next 3Y2.25%
Revenue Next 5Y3.93%
EBIT growth 1Y154.36%
EBIT growth 3YN/A
EBIT growth 5Y-7.67%
EBIT Next Year35.78%
EBIT Next 3Y17.09%
EBIT Next 5Y16.22%
FCF growth 1Y495.24%
FCF growth 3Y28.14%
FCF growth 5Y-3.38%
OCF growth 1Y179.8%
OCF growth 3Y15.37%
OCF growth 5Y-4.45%
ILLUMINA INC / ILU.DE FAQ
What is the ChartMill fundamental rating of ILLUMINA INC (ILU.DE) stock?
ChartMill assigns a fundamental rating of 6 / 10 to ILU.DE.
What is the valuation status of ILLUMINA INC (ILU.DE) stock?
ChartMill assigns a valuation rating of 5 / 10 to ILLUMINA INC (ILU.DE). This can be considered as Fairly Valued.
How profitable is ILLUMINA INC (ILU.DE) stock?
ILLUMINA INC (ILU.DE) has a profitability rating of 7 / 10.
What is the valuation of ILLUMINA INC based on its PE and PB ratios?
The Price/Earnings (PE) ratio for ILLUMINA INC (ILU.DE) is 29.5 and the Price/Book (PB) ratio is 8.25.
What is the earnings growth outlook for ILLUMINA INC?
The Earnings per Share (EPS) of ILLUMINA INC (ILU.DE) is expected to grow by 96.04% in the next year.